IDWeek Program

Interactive Program Available

The Interactive Program is now available. With over 150 sessions to choose from there’s so much to learn and explore! 

Premeeting Workshops

Call for Session Suggestions

Suggest a Session for IDWeek 2022 by Nov. 15

Have a great idea for session next year? Know a fabulous speaker? We want to hear your ideas! Submit a Session Suggestion for IDWeek 2022. You’ll be asked to provide potential learning objectives, possible speaker ideas, and presentation topics. All suggestions are welcome and appreciated.

Because there is a finite limit to how many sessions we can have at IDWeek, the selection process is very competitive. The program committee reserves the right to reject, alter and/or combine suggestions where applicable. IDWeek’s goal is to present cutting-edge science, cover a wide variety of infectious disease topics and provide a forum for scientific discovery and exchange. To better foster inclusion and opportunity at IDWeek, we strive for gender, geographic, practice and ethnic diversity in IDWeek sessions and submissions which achieve these goals have a better chance of being selected. Topics and speakers who have recently presented at IDWeek may not be accepted in a subsequent year to allow for other topics and speakers to participate.

The identity of the session submitter is blinded to the program committee until after the sessions are finalized. Due to the sheer volume, we are unable to provide feedback rationale for accepting, rejecting, or combining submitted sessions. However, accepted sessions will be included on the IDWeek website when finalized and published including any subsequent updates. If the title, topics, speakers, and moderators in a suggested session are accepted with minimal or no changes, the session submitter’s contributions will be acknowledged on the IDWeek website.

As part of IDWeek’s efforts to comport with ACCME policies, one member of the IDWeek Program Committee will serve as a moderator of each session. This moderator will have final authority over the direction and content of session in collaboration with the speakers and will also attest to the session’s balance and scientific objectivity.

IDWeek 2021 Program information coming soon.

IDWeek 2022 CME/CNE/CPE/MOC Credits

In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by, and for, the healthcare team, and learners will receive 223.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

Update infectious diseases clinicians, investigators, infection preventionists, and pharmacists with state of- the-art developments in the field, including timely reviews of recent advances in clinical care and research, and original reports of clinical, translational, and basic research in infectious diseases and healthcare epidemiology.

Bridge the widening gaps among the fields of infectious diseases clinical practice and research, including clinical, epidemiological, health services, implementation, translational and basic research.

Promote multi-disciplinary dialogue and collaboration among clinicians, investigators and pharmacists, thus facilitating advances in the prevention, diagnosis and treatment of infectious diseases.

Provide training in skills that promote the Infectious Disease specialty, including medical education, leadership and advocacy for policies that impact infectious diseases practice and the healthcare team.

Continuing Medical Education

CME Accreditation Statement for Physicians

IDSA designates this other activity (live course and internet enduring material activity) for a maximum of 223.25 PRA Category 1 Credits™. The core IDWeek sessions are designated for 165.25 credit hours and premeeting workshops are an additional 58. Physicians should only claim credit commensurate with the extent of their participation in the activity. 

Continuing Nursing Education

ANCC contact hours will be available.

Continuing Pharmacy Education

CPE Accreditation Statement for Pharmacists
The continuing education activity for pharmacists has been developed by the Infectious Diseases Society of America. IDSA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The registration fee covers the cost of CE credits. CE Statements of Completion will be issued by the Infectious Diseases Society of America (IDSA) at the conclusion of the conference. Participants must complete an evaluation for each session they attended to receive pharmacy CE credit. The deadline for completing the evaluations for the live CE sessions is Dec. 22. IDWeek CPE credits will be transferred to NABP CPE Monitor and visible in accounts within 48 hours, through Dec. 22 for live CE sessions and for on-demand sessions through April 22, 2023.

Maintenance of Certification

Successful completion of this CME activity enables the participant to earn up to 187.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

IDWeek 2022 physician participation information will be shared with ABIM through ACCME PARS.

IDSA, in accordance with Joint Accreditation requirements and ACCME’s new Standards for Integrity and Independence in Accredited Continuing Education, requires everyone who is in a position to control the content of an accredited educational activity to disclose all financial relationships with any ineligible companies (those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients). The ACCME defines financial relationships as financial relationships

in any amount occurring within the past 24 months that exists between the person in control of content and an ineligible company.

Faculty are required to either disclose financial relationships (name of ineligible company and nature of relationship) and include a statement that all relevant financial relationships have been mitigated or indicate that there are no relevant financial relationships. Disclosure to learners must not include ineligible companies’ corporate or product logos, trade names, or product group messages.

IDSA is responsible for ensuring that all CE-accredited activities are fair and balanced, and any clinical content presented supports safe, effective patient care. IDSA must also ensure all decisions related to the planning, faculty selection, delivery, and evaluation of accredited education are free from commercial bias and made without any influence or involvement from the owners and employees of an ineligible company.

IDSA follows and supports the ACCME guidelines for commercial support.

Session Types

Industry sponsored affiliated events include up to 2-hour satellite symposia, 1-hour presentation theaters, and 45-minutes learning lounges.

Program Committee


Adarsh Bhimraj, MD, FIDSA

Houston Methodist Hospital
IDWeek Chair, IDSA

Daniel Morgan, MD, MS

University of Maryland School of Medicine
IDWeek Chair, SHEA

Harry W. Lampiris, DMD, MD

San Francisco VA Med Center
IDWeek Chair, HIVMA

Hayley Gans, MD

Stanford University Medical Center
IDWeek Chair, PIDS

Thank you reviewers!

The IDWeek Program Committee would like to extend a special Thank You to the following individuals who generously donated their time and expertise to review abstracts for IDWeek 2021.

Javier Adachi, MD; UT-MD Anderson Cancer Center 

Sonali Advani, MBBS, MPH; Duke University Medical Center 

Ronda Akins, PharmD; Methodist Charlton Medical Center 

Mayar Al Mohajer, MD MBA; Baylor College of Medicine 

Andrés Alarcón, MD, MPH; Children’s National Medical Center/FDA 

Fritzie Albarillo, MD; Loyola University Medical Center 

Maria Alcaide, MD; University of Miami Miller School of Medicine 

Bryan Alexander, PharmD; Nebraska Medicine 

Majdi Al-Hasan, MD; University of South Carolina School of Medicine 

Rahul Anand, MBA, MS; Quinnipiac University 

Evan Anderson, MD; Emory University 

David Andes, MD; University of Wisconsin Hospital 

Michael Angarone, DO; Northwestern Memorial Hospital 

Shweta Anjan, MD; University of Miami 

Senu Apewokin, MD; University of Cincinnati 

Monica Ardura, DO, MSc; Nationwide Children’s Hospital 

Wendy Armstrong, MD, FIDSA; Emory University School of Medicine 

Naomi Aronson, MD; Uniformed Services University of the Health Sciences 

Aparna Arun, MD; Stanford University School of Medicine 

michael Augenbraun, MD; SUNY Downstate Medical Center 

Skip to content